These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7504461)

  • 1. Transformation of NIH3T3 cells with ras oncogenes abrogates the retinoic acid induction of tissue transglutaminase.
    Kosa K; Meyers K; De Luca LM
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1025-33. PubMed ID: 7504461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The H-ras oncogene interferes with retinoic acid signaling and metabolism in NIH3T3 cells.
    Kósa K; Jones CS; De Luca LM
    Cancer Res; 1995 Nov; 55(21):4850-4. PubMed ID: 7585519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of retinoic acid on NIH3T3 cell transformation by the H-ras oncogene.
    Cox LR; Motz J; Troll W; Garte SJ
    J Cancer Res Clin Oncol; 1991; 117(2):102-8. PubMed ID: 1706723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the Ras-ERK pathway inhibits retinoic acid-induced stimulation of tissue transglutaminase expression in NIH3T3 cells.
    Antonyak MA; McNeill CJ; Wakshlag JJ; Boehm JE; Cerione RA
    J Biol Chem; 2003 May; 278(18):15859-66. PubMed ID: 12604597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
    Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum growth factors up-regulate H-ras, K-ras, and N-ras proto-oncogenes in fibroblasts.
    Quincoces AF; León J
    Cell Growth Differ; 1995 Mar; 6(3):271-9. PubMed ID: 7794795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Harvey-ras is biochemically different from Kirsten- or N-ras.
    Carbone A; Gusella GL; Radzioch D; Varesio L
    Oncogene; 1991 May; 6(5):731-7. PubMed ID: 1905005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a dominant-negative retinoic acid receptor construct reduces retinoic acid metabolism and retinoic acid-induced inhibition of NIH-3T3 cell growth.
    Isogai M; Chiantore MV; Haque M; Scita G; De Luca LM
    Cancer Res; 1997 Oct; 57(20):4460-4. PubMed ID: 9377552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive autoregulation of ras genes expression in fibroblasts.
    Quincoces AF; Polanco I; Thomson T; León J
    FEBS Lett; 1997 Oct; 416(3):317-23. PubMed ID: 9373177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased retinoylation in NIH 3T3 cells transformed with activated Ha-ras.
    Takahashi N; De Luca LM; Breitman TR
    Biochem Biophys Res Commun; 1997 Oct; 239(1):80-4. PubMed ID: 9345273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of H-ras-mediated transformation in NIH3T3 cells by a ras ribozyme.
    Funato T; Shitara T; Tone T; Jiao L; Kashani-Sabet M; Scanlon KJ
    Biochem Pharmacol; 1994 Oct; 48(7):1471-5. PubMed ID: 7945447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of retinoic acid action. Transcriptional regulation of tissue transglutaminase gene expression in macrophages.
    Chiocca EA; Davies PJ; Stein JP
    J Biol Chem; 1988 Aug; 263(23):11584-9. PubMed ID: 2900242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes.
    Sklar MD
    Cancer Res; 1988 Feb; 48(4):793-7. PubMed ID: 3276398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of retinoic acid nuclear receptors in retinoic acid-induced tissue transglutaminase gene expression in rat tracheal 2C5 cells.
    Denning MF; Verma AK
    Biochem Biophys Res Commun; 1991 Feb; 175(1):344-50. PubMed ID: 1705423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid and 4-hydroxyphenylretinamide induce growth inhibition and tissue transglutaminase through different signal transduction pathways in mouse fibroblasts (NIH 3T3 cells).
    Giandomenico V; Andreola F; Rodriguez de la Concepcion ML; Collins SJ; De Luca LM
    Carcinogenesis; 1999 Jun; 20(6):1133-5. PubMed ID: 10357800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Integration of DNA oscillatory vector pSV neo to genome of NIH3T3: importance in investigations of transformation with c-Ha-ras oncogene].
    Burzyński A; Wiśniewski R; Wojciechowski W; Porwit-Bóbr Z
    Med Dosw Mikrobiol; 1994; 46(1-2):35-41. PubMed ID: 7967925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes.
    Izumi H; Takahashi C; Oh J; Noda M
    FEBS Lett; 2000 Sep; 481(1):31-6. PubMed ID: 10984610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of differentiation in PA-1 human teratocarcinoma cells after N-ras oncogene-induced tumorigenicity.
    Tainsky MA; Yim SO; Krizman DB; Kannan P; Chiao PJ; Mukhopadhyay T; Buettner R
    Oncogene; 1991 Sep; 6(9):1575-82. PubMed ID: 1681491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of 3T3-L1 fibroblasts to adipocytes induced by transfection of ras oncogenes.
    Benito M; Porras A; Nebreda AR; Santos E
    Science; 1991 Aug; 253(5019):565-8. PubMed ID: 1857988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipain-induced suppression of oncogene expression in H-ras-transformed NIH3T3 cells.
    Cox LR; Motz J; Troll W; Garte SJ
    Cancer Res; 1991 Sep; 51(18):4810-4. PubMed ID: 1893373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.